Absolute DNA Services has streamlined the process for the Pharmacogenomics Panel, so it’s as easy as:
As everyone has a unique genetic makeup, this can affect how you will respond or react to certain medications. A medication or dose that works for one person may be ineffective or cause harmful side effects for another. Through pharmacogenomics testing, individualised medicine treatment plans can be developed based on each patient’s genetic makeup to determine optimal drugs and dosages, and limit harmful side effects. The way in which medications are metabolised is largely dependent on your unique genetic makeup. Some medications are used by the body quickly, while others are slower to react. This can change how successful a medication is for you and your needs.
PGx testing is available to everyone but may be most useful for patients who are currently on, or about to begin taking, medications for any of the conditions covered. It may also be useful for people who have tried numerous drugs to find one that may effectively treat their symptoms.
PGx is particularly relevant in psychiatry where antidepressants are essential components in treatment. Around 30-50% of patients do not respond to their first antidepressant and lengthy trials are often required before the optimal treatment type and dose is identified. Patients who have had genetically guided prescribing may have a greater chance of remission compared to patients without genetic prescribing.
Our PGx panel also covers over 60 common oncology drugs. For cancer patients who are about to commence treatment, this may help identify which drugs are likely to be effective. For cancer patients who are currently on treatment, PGx testing may identify new treatment options or identify if and why current medications aren’t effective.
Our Pharmacogenomics Panel uses next generation sequencing to analyse genes related to 40 known drug-metabolizing enzymes (DMEs) – ABCB1, ABCG2, ADRA2A, ANKK1, APOE, COMT, CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, DBH, DPYD, DRD1, DRD4, F2, F5, GABRA6, GABRP, GRIK4, HLA-A*3101, HLAB*1502, HLA-B*5701, HTR2A, HTR2C, ITGB3, KIF6, MTHFR, OPRD1, OPRK1, OPRM1, SLCO1B1, TPMT, UGT1A1, UGT2B15, UGT2B7 and VKORC1.
There are 12 PGx panels available, and the initial cost is for 2 tests. Additional tests can be purchased by arrangement.
Click below to explore what medication each unique panel targets!
Discover your ability to metabolise the following medications: